Literature DB >> 21543979

Infection prevention and control in cystic fibrosis.

Lisa Saiman1.   

Abstract

PURPOSE OF REVIEW: This review will discuss recent studies of the virulence of cystic fibrosis (CF) pathogens, including epidemic strains, a more complex understanding of droplet transmission, bacterial contamination of CF clinics, and identifying and overcoming barriers to implementation of infection control guidelines. RECENT
FINDINGS: Both morbidity and mortality are associated with methicillin-resistant Staphylococcus aureus (MRSA). Thus, clinicians are attempting eradication strategies for MRSA using combinations of oral, aerosolized, intravenous, and topical antibiotics, with some success. However, household contacts may be colonized with MRSA, which can impact the durability of eradication. Epidemic strains of Pseudomonas aeruginosa are also associated with increased morbidity and mortality and some clones are detected in CF patients throughout the world presumably due to social networks among patients. Recent experimental and clinical data have suggested that CF patients can generate droplet nuclei in the respirable range and that infectious particles can be cultured from room air minutes to hours after patients have left.
SUMMARY: Although these observations regarding droplet nuclei have not been linked to transmission, they do challenge the safety of the '3-foot rule' and suggest the potential role of masks. Additional research is needed to develop strategies to improve infection control practices among healthcare professionals, CF patients, and families.

Entities:  

Mesh:

Year:  2011        PMID: 21543979     DOI: 10.1097/QCO.0b013e32834748ff

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  9 in total

1.  Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.

Authors:  Rosana H V Pereira; Ana Paula Carvalho-Assef; Rodolpho M Albano; Tania W Folescu; Marcia C M F Jones; Robson S Leão; Elizabeth A Marques
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

2.  Carriage of a Single Strain of Nontoxigenic Corynebacterium diphtheriae bv. Belfanti (Corynebacterium belfantii) in Four Patients with Cystic Fibrosis.

Authors:  Diane Pivot; Annlyse Fanton; Edgar Badell-Ocando; Marion Benouachkou; Karine Astruc; Frederic Huet; Lucie Amoureux; Catherine Neuwirth; Alexis Criscuolo; Serge Aho; Julie Toubiana; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 4.  Host-pathogen interplay in the respiratory environment of cystic fibrosis.

Authors:  Lael M Yonker; Cristina Cigana; Bryan P Hurley; Alessandra Bragonzi
Journal:  J Cyst Fibros       Date:  2015-03-19       Impact factor: 5.482

5.  Data Mining of Lung Microbiota in Cystic Fibrosis Patients.

Authors:  Jianguo Li; Chunyan Hao; Lili Ren; Yan Xiao; Jianwei Wang; Xuemei Qin
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

6.  Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection.

Authors:  Sharif M Abdelghany; Derek J Quinn; Rebecca J Ingram; Brendan F Gilmore; Ryan F Donnelly; Clifford C Taggart; Christopher J Scott
Journal:  Int J Nanomedicine       Date:  2012-07-26

7.  Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

Authors:  Luke D Knibbs; Graham R Johnson; Timothy J Kidd; Joyce Cheney; Keith Grimwood; Jacqueline A Kattenbelt; Peter K O'Rourke; Kay A Ramsay; Peter D Sly; Claire E Wainwright; Michelle E Wood; Lidia Morawska; Scott C Bell
Journal:  Thorax       Date:  2014-04-17       Impact factor: 9.139

8.  Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit.

Authors:  Maika Furukawa; John McCaughan; Jonathan Stirling; B Cherie Millar; Charlotte Addy; Steven Caskey; Colin E Goldsmith; Jacqueline C Rendall; Naoaki Misawa; Damian G Downey; John E Moore
Journal:  Ulster Med J       Date:  2020-02-18

9.  Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.

Authors:  Pedro Mondejar-Lopez; Esther Quintana-Gallego; Rosa M Giron-Moreno; Isidoro Cortell-Aznar; Marta Ruiz de Valbuena-Maiz; Layla Diab-Caceres; Concepcion Prados-Sanchez; Antonio Alvarez-Fernandez; Patricia W Garcia-Marcos; Carlos Peñalver-Mellado; M Dolores Pastor-Vivero; Casilda Olveira; Alejandro Lopez-Neyra; Silvia Castillo-Corullon; Samara Palma-Milla; Estela Perez-Ruiz; Amparo Sole-Jover; M Isabel Barrio; Manuel Sanchez-Solis; Óscar Asensio de la Cruz
Journal:  Respir Med       Date:  2020-06-08       Impact factor: 4.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.